MCDERMOTT WILL & EMERY REPRESENTS APPLIED DNA SCIENCES IN ITS $12M PUBLIC OFFERING
July 19, 2024
July 19, 2024
CHICAGO, Illinois, July 19 -- McDermott Will and Emery, a law firm, issued the following news release:
International law firm McDermott Will & Emery represented Applied DNA Sciences, Inc. (Applied DNA), a leader in PCR-based DNA technologies, in its $12 million public offering.
The offering is comprised of 9,230,769 Units with each Unit consisting of one share of common stock (or pre-funded warrant), one Series A Warrant to purchase one share of common stock exercis . . .
International law firm McDermott Will & Emery represented Applied DNA Sciences, Inc. (Applied DNA), a leader in PCR-based DNA technologies, in its $12 million public offering.
The offering is comprised of 9,230,769 Units with each Unit consisting of one share of common stock (or pre-funded warrant), one Series A Warrant to purchase one share of common stock exercis . . .